Innovative MedTech, Inc.
IMTH
$0.688
$0.31684.95%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | -26.92% | -2.67% | 5.80% | 10.46% | 26.03% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -26.92% | -2.67% | 5.80% | 10.46% | 26.03% |
| Cost of Revenue | -69.86% | -79.00% | -81.37% | -60.93% | -27.98% |
| Gross Profit | 167.54% | 141.26% | 126.89% | 91.50% | 47.66% |
| SG&A Expenses | 531.58% | 334.87% | 280.79% | -90.32% | -94.25% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 113.96% | 34.59% | 4.75% | -84.92% | -84.07% |
| Operating Income | -198.13% | -74.18% | -16.19% | 90.46% | 90.01% |
| Income Before Tax | -387.34% | -205.73% | -116.03% | 89.85% | 89.96% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -387.34% | -205.73% | -116.03% | 89.85% | 89.96% |
| Earnings from Discontinued Operations | 73.71% | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -374.08% | -207.80% | -117.62% | 89.57% | 89.66% |
| EBIT | -198.13% | -74.18% | -16.19% | 90.46% | 90.01% |
| EBITDA | -206.11% | -76.24% | -15.92% | 90.75% | 90.33% |
| EPS Basic | -272.73% | -147.52% | -76.87% | 90.25% | 90.35% |
| Normalized Basic EPS | -143.28% | -47.41% | 0.28% | 90.48% | 90.76% |
| EPS Diluted | -259.94% | -141.35% | -73.45% | 90.19% | 90.05% |
| Normalized Diluted EPS | -143.28% | -47.41% | 0.28% | 90.48% | 90.76% |
| Average Basic Shares Outstanding | 26.40% | 14.90% | 7.14% | 1.92% | 9.15% |
| Average Diluted Shares Outstanding | 26.40% | 14.90% | 7.14% | 1.92% | 9.15% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
